Junshi Biosciences Announces Full Year 2020 Financial Results And Provides Corporate Updates
SHANGHAI, China, March 30 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced financial results for the full year 2020 and provided corporate updates. Full Year 2020 Financial Highlights Total revenues increased 106% to RMB1,595 million for the full [...]










